ONCOSEC MEDICAL Inc Quarterly Interest Expense in USD from Q1 2011 to Q4 2022

Taxonomy & unit
us-gaap: USD
Description
Amount of the cost of borrowed funds accounted for as interest expense.
Summary
ONCOSEC MEDICAL Inc quarterly/annual Interest Expense history and growth rate from Q1 2011 to Q4 2022.
  • ONCOSEC MEDICAL Inc Interest Expense for the quarter ending January 31, 2023 was $33.6K, a 523% increase year-over-year.
  • ONCOSEC MEDICAL Inc Interest Expense for the twelve months ending January 31, 2023 was $52.1K, a 183% increase year-over-year.
  • ONCOSEC MEDICAL Inc annual Interest Expense for 2022 was $20.9K, a 32% increase from 2021.
  • ONCOSEC MEDICAL Inc annual Interest Expense for 2021 was $15.9K, a 210% increase from 2020.
  • ONCOSEC MEDICAL Inc annual Interest Expense for 2020 was $5.11K, a 34.4% increase from 2019.
Interest Expense, Trailing 12 Months (USD)
Interest Expense, Quarterly (USD)
Interest Expense, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q4 2022 $52.1K $33.6K +$28.2K +523% Nov 1, 2022 Jan 31, 2023 10-Q 2023-03-14
Q3 2022 $24K $11.1K +$3.04K +37.7% Aug 1, 2022 Oct 31, 2022 10-Q 2022-12-15
Q2 2022 $20.9K $4.8K +$1.53K +46.7% May 1, 2022 Jul 31, 2022 10-K 2022-10-31
Q1 2022 $19.4K $2.7K +$969 +55.9% Feb 1, 2022 Apr 30, 2022 10-Q 2022-06-14
Q4 2021 $18.4K $5.38K +$660 +14% Nov 1, 2021 Jan 31, 2022 10-Q 2023-03-14
Q3 2021 $17.8K $8.05K +$1.91K +31.2% Aug 1, 2021 Oct 31, 2021 10-Q 2022-12-15
Q2 2021 $15.9K $3.27K May 1, 2021 Jul 31, 2021 10-K 2022-10-31
Q1 2021 $1.73K Feb 1, 2021 Apr 30, 2021 10-Q 2022-06-14
Q4 2020 $4.72K +$4.64K +5954% Nov 1, 2020 Jan 31, 2021 10-Q 2022-03-15
Q3 2020 $6.13K +$5.14K +518% Aug 1, 2020 Oct 31, 2020 10-Q 2021-12-15
Q4 2019 $78.00 Nov 1, 2019 Jan 31, 2020 10-Q 2021-03-15
Q3 2019 $992 Aug 1, 2019 Oct 31, 2019 10-Q 2020-12-11
Q1 2019 $987 Feb 1, 2019 Apr 30, 2019 10-Q 2020-06-15
Q1 2011 $1.4K Feb 1, 2011 Apr 30, 2011 10-Q 2012-06-14
* An asterisk sign (*) next to the value indicates that the value is likely invalid.